VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
USPH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
USPHU.S. Physical Therapy, Inc.
$83.17$1.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksUSPHBalance Sheet

U.S. Physical Therapy, Inc. (USPH) Balance Sheet

30Y historyFree accessUpdated daily

The balance sheet is structurally dominated by goodwill from acquisitions, with intangible assets comprising 59% of total assets ($716.5M out of $1.2B), while leverage spiked with a D/E ratio of 0.46 in Q1 2026 before a recent partial reduction to 0.22 in Q2 2026 following a major debt repayment.

Income StatementBalance SheetCash FlowRatios

USPH Balance Sheet

Annual statement

USPH Balance Sheet

U.S. Physical Therapy, Inc. (USPH) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets139.68M139.99M137.58M233.38M111.27M95.17M87.64M85.39M79.21M77.08M65.96M60.18M54.85M49.66M45.32M45.67M39.28M32.84M38.72M36.03M35.98M36.85M40.61M33.02M23.08M22.41M13.74M14.65M15.6M14M11.8M
Cash & Short-Term Investments24.89M35.57M41.36M152.82M31.59M28.57M32.92M23.55M23.37M21.93M20.05M15.78M14.27M12.9M11.67M9.98M9.18M6.43M10.11M7.98M11.45M15M20.55M16.82M7.61M8.12M2.07M4.03M6.3M5.6M4.9M
Cash Only24.89M35.57M41.36M152.82M31.59M28.57M32.92M23.55M23.37M21.93M20.05M15.78M14.27M12.9M11.67M9.98M9.18M6.43M10.11M7.98M10.95M15M20.55M16.82M7.61M8.12M2.07M4.03M6.3M5.6M4.9M
Short-Term Investments00000000000000000000500K0000000000
Accounts Receivable69.6M88.34M85.67M69.72M69.31M62.42M50.95M56.05M51.49M50.36M41.49M38.62M34.59M32.66M27.68M29.95M26.37M23.63M26.75M26.72M22.28M20.42M18.22M14.4M13.68M13.65M11.15M9.99M8.7M7.9M6.5M
Days Sales Outstanding44.8241.2846.5842.0845.7346.0243.9642.4541.4144.442.4742.5541.3945.1540.0746.1245.5642.8252.0264.3160.1556.4256.2149.7952.761.5464.3973.0172.1774.3273.68
Inventory0000000000000000000000000000000
Days Inventory Outstanding-------------------------------
Other Current Assets45.19M16.08M10.55M10.83M10.37M4.18M3.77M5.79M11.1M10.44M7.08M8.19M7.69M5.94M7.68M7.35M3.74M2.96M1.86M1.33M2.25M1.43M1.83M1.8M1.79M646K519K630K600K500K400K
Total Non-Current Assets1.11B1.06B1.03B763.86M746.89M654.26M506.73M475.46M363.95M341.9M285.27M219.73M189.7M174.47M126.39M117.58M101.58M78.41M79.53M60.22M35.48M29.67M21M19.45M17.95M13.77M9.23M8.7M8.5M8.5M7.7M
Property, Plant & Equipment291M271.07M166.08M129.53M127.75M119.41M103.26M103.68M20.17M20.39M19.17M16.65M15.76M14.96M13.02M13.19M13.92M14.34M15.84M16.79M13.37M13.74M13.65M11.81M10.41M7.8M6.99M6.49M6.4M6M6M
Fixed Asset Turnover3.05x2.88x4.04x4.67x4.33x4.15x4.10x4.65x22.51x20.31x18.60x19.89x19.35x17.65x19.37x17.97x15.17x14.05x11.85x9.03x10.11x9.62x8.67x8.94x9.10x10.37x9.04x7.70x6.88x6.47x5.37x
Goodwill716.53M692.39M667.15M509.57M494.1M434.68M345.65M317.68M293.52M271.34M226.81M171.55M147.91M143.96M100.19M92.75M79.42M57.25M55.89M37.65M21M0000000000
Intangible Assets176.55M172.86M179.31M109.68M108.75M86.38M56.28M52.59M48.83M48.95M38.06M30.3M24.91M14.48M12.15M9.6M7.31M5.96M6.45M3.93M014.34M6.13M5.68M5.59M4.52M897K948K1M1.2M800K
Long-Term Investments37.01M12.28M12.19M12.26M12.13M12.21M00-2.48M-2.06M-2.54M-2.35M0000000000000000000
Other Non-Current Assets-74.88M-84.58M5.16M2.82M4.15M1.58M1.54M1.52M1.43M1.22M1.23M1.23M1.11M1.08M1.04M2.04M922K869K1.35M1.85M1.11M1.59M1.23M1.96M1.95M1.45M1.34M1.26M1.1M1.3M900K
Total Assets1.25B1.2B1.17B997.24M858.15M749.43M594.36M560.85M443.17M418.98M351.23M279.91M244.55M224.13M171.71M163.25M140.86M111.25M118.25M96.25M71.46M66.52M61.61M52.47M41.03M36.18M22.97M23.35M24.1M22.5M19.5M
Asset Turnover0.58x0.65x0.58x0.61x0.64x0.66x0.71x0.86x1.02x0.99x1.02x1.18x1.25x1.18x1.47x1.45x1.50x1.81x1.59x1.58x1.89x1.99x1.92x2.01x2.31x2.24x2.75x2.14x1.83x1.72x1.65x
Asset Growth %30.52%3.13%17.07%16.21%14.51%26.09%5.98%26.55%5.77%19.29%25.48%14.46%9.11%30.53%5.18%15.9%26.61%-5.91%22.85%34.7%7.42%7.97%17.41%27.88%13.4%57.53%-1.61%-3.13%7.11%15.38%22.64%
Total Current Liabilities109.91M139.04M116.28M102.19M85.49M83.48M93.49M60.56M41.95M39.55M24.62M19.01M25.5M23.17M16.31M16.32M14.23M14.59M14.61M11.44M9.17M7.12M5.62M5.42M2.85M3.25M3.32M2.16M2.6M2.8M2.6M
Accounts Payable6.92M6.06M5.94M3.9M6.5M6.47M1.33M2.49M2.02M2.17M1.63M1.64M1.78M1.72M1.73M1.81M1.24M1.29M1.48M1.55M1.6M1.72M1.18M498K624K539K434K349K600K300K300K
Days Payables Outstanding4.53.553.962.945.386.251.482.462.092.442.172.362.843.153.343.832.973.223.864.965.886.535.052.443.533.583.693.747.114.014.95
Short-Term Debt47.43M52M11M7.69M7.86M830K4.9M728K1.43M4.04M1.23M775K883K825K459K433K250K1.01M1.38M812K562K244K70K2.37M4K701K912K39K0100K100K
Deferred Revenue (Current)1.03M000000002.83M0000000-175K0000002.19M1.9M00000
Other Current Liabilities62.48M80.98M022.49M000016.77M9.52M11.19M5.71M5.61M6.57M2.85M4.01M3.75M3.33M5.25M4.17M4.76M3.01M0033K-445K1.98M1.77M2M2.4M2.2M
Current Ratio1.27x1.01x1.18x2.28x1.30x1.14x0.94x1.41x1.89x1.95x2.68x3.17x2.15x2.14x2.78x2.80x2.76x2.25x2.65x3.15x3.92x5.18x7.23x6.09x8.10x6.90x4.14x6.79x6.00x5.00x4.54x
Quick Ratio1.27x1.01x1.18x2.28x1.30x1.14x0.94x1.41x1.89x1.95x2.68x3.17x2.15x2.14x2.78x2.80x2.76x2.25x2.65x3.15x3.92x5.18x7.23x6.09x8.10x6.90x4.14x6.79x6.00x5.00x4.54x
Cash Conversion Cycle40.33------------------------------
Total Non-Current Liabilities372.31M294.77M292.14M242.81M288.1M213.5M90.9M120.83M50.4M70.46M68.74M58.95M44.46M45.84M20.75M25.35M10.25M4.44M15.81M9.76M2.9M2.9M2.5M429K2.62M3.02M7.23M8.09M8.2M8.1M8.3M
Long-Term Debt123.79M263.17M142.53M138.99M175.83M117.59M16.6M50.36M38.4M56.73M50.6M48.34M34.73M40.65M17.57M23.78M5.75M400K12.41M7.96M797K483K083K2.35M3.02M7.23M8.09M8.1M8.2M8.3M
Capital Lease Obligations331.96M110.57M101.87M76.65M77.93M74.19M61.98M60.26M00000000000000000000000
Deferred Tax Liabilities94.86M28.39M29.46M24.82M21.3M14.38M7.78M10.07M9.01M10.88M15.74M9.22M0000000000000000000
Other Non-Current Liabilities248.52M-107.36M18.27M2.36M13.03M7.34M4.54M141K12M13.73M18.14M1.4M9.72M5.19M3.17M623K3.53M3.01M3.4M1.8M2.1M2.42M2.5M346K273K000100K-100K0
Total Liabilities482.22M433.81M408.42M345M373.59M296.98M184.39M181.39M92.35M110.01M93.35M77.96M69.96M69.01M37.05M41.67M24.48M19.03M30.43M21.2M12.07M10.02M8.12M5.85M5.47M6.27M10.55M10.24M10.8M10.9M10.9M
Total Debt171.22M425.74M295.23M258.59M295.34M223.08M110.99M137.83M39.84M60.77M51.82M49.11M35.62M41.48M18.03M24.22M6M1.41M13.79M8.77M1.36M727K70K2.46M2.35M3.72M8.14M8.13M8.1M8.3M8.4M
Net Debt146.34M390.17M253.87M105.76M263.74M194.51M78.07M114.28M16.47M38.84M31.78M33.33M21.35M28.58M6.36M14.23M-3.18M-5.02M3.68M795K-9.59M-14.28M-20.48M-14.37M-5.26M-4.4M6.07M4.1M1.8M2.7M3.5M
Debt / Equity0.22x0.55x0.39x0.40x0.61x0.49x0.27x0.36x0.11x0.20x0.20x0.24x0.20x0.27x0.13x0.20x0.05x0.02x0.16x0.12x0.02x0.01x0.00x0.05x0.07x0.12x0.66x0.62x0.61x0.72x0.98x
Debt / EBITDA1.61x4.14x3.61x3.82x4.13x2.71x1.76x1.78x0.57x0.94x0.89x0.89x0.68x0.94x0.42x0.59x0.15x0.04x0.46x0.35x0.06x0.03x0.00x0.12x0.11x0.19x0.64x0.87x1.07x1.24x1.58x
Net Debt / EBITDA1.38x3.79x3.10x1.56x3.69x2.37x1.24x1.47x0.24x0.60x0.54x0.60x0.41x0.64x0.15x0.34x-0.08x-0.15x0.12x0.03x-0.42x-0.62x-1.01x-0.70x-0.24x-0.23x0.48x0.44x0.24x0.40x0.66x
Interest Coverage-44.90x9.23x8.51x6.31x10.62x78.70x41.09x35.11x30.49x2.60x4.32x6.54x6.14x72.08x68.96x74.34x143.12x80.28x44.53x66.56x---89.64x87.79x63.71x13.31x9.99x7.86x-5.14x
Total Equity766.15M769.74M759.05M652.24M484.57M452.44M409.97M379.45M350.82M308.97M257.88M201.95M174.59M155.12M134.66M121.58M116.38M92.22M87.82M75.06M59.39M56.5M53.49M46.63M35.56M29.91M12.42M13.1M13.3M11.6M8.6M
Equity Growth %21.28%1.41%16.38%34.6%7.1%10.36%8.04%8.16%13.54%19.81%27.69%15.67%12.55%15.2%10.76%4.47%26.19%5.01%17.01%26.38%5.11%5.63%14.72%31.11%18.87%140.84%-5.2%-1.48%14.66%34.88%45.76%
Book Value per Share50.6850.7250.3945.9737.3235.0831.9429.7527.7024.5820.6316.3014.2912.8411.3110.159.807.817.296.415.084.694.333.882.812.331.161.331.231.070.81
Total Shareholders' Equity448.66M476.43M488.93M476.19M315.79M295.61M276.16M240.26M215.94M204.87M187.55M162.78M146.28M128.29M117.32M107.05M103.96M87.35M81.61M69.41M55.52M53.48M50.18M43.35M32.54M26.67M9.56M10.72M11.6M10M7.6M
Common Stock175K174K172K172K152K151K151K150K149K148K147K146K145K143K141K139K139K138K142K141K137K136K134K122K118K107K57K36K000
Retained Earnings213.36M227.22M227.26M223.77M232.95M224.4M212.01M184.35M167.4M162.41M150.34M149.02M134.19M119.21M111.32M102.41M89.88M81.21M69.45M59.44M50.7M44.41M35.62M28.94M21.61M13.12M6.05M2.31M-100K-1.7M-4.1M
Treasury Stock0-37.19M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-31.63M-26.11M-18.11M-12.52M-12.5M-1.99M-47K-47K000
Accumulated OCI0714K2.8M2.78M4M000-64.15M-60.48M-56.02M-53.26M-49.05M0-44.16M-42.3M-39.23M-36.65M-33.17M-29.34M-25.57M-23.82M-23.04M-19.55M-16.69M-13.8M-11.46M-3.45M-7.6M-6M-4.3M
Minority Interest317.49M293.31M270.12M176.04M168.78M156.84M133.81M139.19M134.87M104.1M70.33M39.17M28.31M26.83M17.34M14.53M12.43M4.87M6.21M5.65M3.87M3.02M3.31M3.28M3.02M3.25M2.86M2.38M1.7M1.6M1M

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetAdequate
Cash FlowDeteriorating
Top Statement Risk

Goodwill concentration and cash erosion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Leverage Expansion Erodes Equity Base

The balance sheet trajectory shows a notable weakening, with total liabilities growing 40% since 2024Q1 while equity has contracted, driving the D/E ratio from 0.38 to 0.46 by Q1 2026 before a recent partial deleveraging.

The sharp increase in total liabilities from $345.3M in 2024Q1 to $482.2M in 2026Q2 appears driven primarily by debt expansion, which suggests the company's growth strategy is increasingly reliant on external financing rather than retained earnings. This trend is coupled with a decline in retained earnings from a peak of $237.3M in 2025Q3 to $213.4M most recently, indicating that shareholder returns or operating losses are eroding the equity buffer. Investors should monitor whether this leverage increase is funding productive acquisitions or masking underlying operational weakness, especially given the concurrent margin pressure noted in the income statement.

Debt Reduction Follows Aggressive Accumulation

U.S. Physical Therapy's total debt has been volatile, peaking at $425.7M in Q4 2025 before a significant reduction to $171.2M by Q2 2026, suggesting an active and large-scale refinancing or repayment event has recently occurred.

The dramatic shift in debt levels from $362.8M to $171.2M in a single quarter is a material deleveraging event that has improved the D/E ratio from 0.46 to 0.22. This action appears strategic, potentially capitalizing on a strong cash flow quarter or an equity raise, though the cash balance declined modestly, which may indicate the repayment was funded by operating cash flow or asset sales rather than a pure cash windfall. The current debt level is below the 10-quarter average, but the prior volatility indicates a balance sheet that can shift rapidly, warranting investigation into the specific instrument repaid and its terms.

Goodwill Dominance Heightens Impairment Risk

Goodwill and intangible assets constitute a staggering 59% of total assets ($716.5M out of $1.2B), while tangible assets like PPE represent a much smaller fraction, highlighting the company's acquisition-driven growth model.

The asset mix is heavily skewed towards goodwill, which has grown steadily from $534.3M to $716.5M over the period, directly reflecting the company's acquisition strategy. This concentration means the balance sheet's strength is largely contingent on the success of past acquisitions and the performance of acquired clinic networks. Any impairment of this goodwill would severely impact reported equity and could trigger covenant issues, making the quality and cash flow generation of these acquired assets a critical, though opaque, focus for investors.

Diminished Cash Buffer Increases Near-Term Risk

Cash reserves have plummeted by 81% from a peak of $132.3M in Q1 2024 to just $24.9M in Q2 2026, drastically reducing the company's liquidity cushion against operational or financing shocks.

The decline in cash from $132.3M to $24.9M over ten quarters, concurrent with a drop in the current ratio from 2.16 to 1.27, signals a significant tightening of the liquidity position. This erosion appears driven by the combination of aggressive capital deployment for acquisitions and shareholder returns, as noted in cash flow analysis, against a backdrop of volatile operating cash flows. While the current ratio remains above 1.0, the minimal cash on hand leaves the company with a narrow margin for error and likely increases its dependence on revolver facilities or future financing for operational needs.

Acquisition-Fueled Model Masks Organic Weakness

The balance sheet is structurally dominated by goodwill from acquisitions, which may be obscuring a more concerning trend of declining organic equity growth and shrinking tangible book value.

Stripping out goodwill, tangible assets are only $483.5M against $482.2M in total liabilities, resulting in a near-zero tangible net worth. This suggests that the company's reported equity of $448.7M is almost entirely a function of acquisition accounting. Combined with the falling retained earnings and volatile profitability, this raises a key question: is the business generating sufficient organic earnings to sustain its goodwill-laden balance sheet, or is it reliant on a continuous cycle of debt-funded acquisitions to maintain its reported growth and equity base? This structural vulnerability could be exacerbated by any downturn in the elective physical therapy market or tightening of insurance reimbursement rates.

USPH — Frequently Asked Questions

Quick answers to the most common questions about buying USPH stock.

What are the total assets of U.S. Physical Therapy, Inc. (USPH)?

As of 2025, U.S. Physical Therapy, Inc. (USPH) had total assets of $1.20B including $140.0M in current assets.

How much debt does U.S. Physical Therapy, Inc. (USPH) have?

U.S. Physical Therapy, Inc. (USPH) carries total debt of $425.7M, offset by $35.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of U.S. Physical Therapy, Inc.?

U.S. Physical Therapy, Inc. (USPH) has total shareholders' equity (book value) of $476.4M ($50.72 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is U.S. Physical Therapy, Inc.'s current ratio and liquidity?

U.S. Physical Therapy, Inc. (USPH) reported a current ratio of 1.01x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.